Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers.
Giuseppe FacondoGianluca VulloVitaliana De SanctisMargherita RotondiRiccardo Carlo SigilloMaurizio ValerianiMattia Falchetto OstiPublished in: Journal of personalized medicine (2023)
SBRT for lymph node recurrence offers excellent in-field tumor control with safe profile and low toxicities. Size, number of oligometastases, and time primary tumor to RT seem to be significant prognostic factors.